Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nathan Shaffer

Showing results (1-10 of 55) with videos related to

Pageof 6
Sort By:
Lancet (London, England)|April 16, 2013
Is Option B+ the best choice?Gottfried Hirnschall, Meg Doherty, Nathan Shaffer
Biomedical Physics & Engineering Express|December 16, 2024
Validation of a rapid algorithm for repeated intensity modulated radiation therapy dose calculationsNathan Shaffer, Jeffrey Snyder, Joel St-Aubin
Journal of Acquired Immune Deficiency Syndromes (1999)|June 5, 2002
Prevention of mother-to-child HIV transmission in the context of a comprehensive AIDS agenda in resource-poor countriesEve M Lackritz, Nathan Shaffer, Chewe Luo
AIDS (London, England)|January 29, 2014
Option B+ for prevention of mother-to-child transmission of HIV in resource-constrained settings: great promise but some early cautionNathan Shaffer, Elaine J Abrams, Renaud Becquet
Medical Physics|January 30, 2026
A tandem reinforcement learning framework for localized prostate cancer treatment planning and machine parameter optimizationNathan Shaffer, Avinash Reddy Mudireddy, Joel St-Aubin
AIDS (London, England)|January 29, 2014
The costs and benefits of Option B+ for the prevention of mother-to-child transmission of HIVChaitra Gopalappa, John Stover, Nathan Shaffer, et al.
Bulletin of the World Health Organization|April 5, 2014
The incremental cost of switching from Option B to Option B+ for the prevention of mother-to-child transmission of HIVLisa O'Brien, Nathan Shaffer, Nalinee Sangrujee, et al.
Lancet (London, England)|December 4, 2009
New WHO HIV treatment and prevention guidelinesSiobhan Crowley, Nigel Rollins, Nathan Shaffer, et al.
Bulletin of the World Health Organization|March 31, 2005
Should nevirapine be used to prevent mother-to-child transmission of HIV among women of unknown serostatus?Tin Tin Sint, François Dabis, Claude Kamenga, et al.
AIDS Care|May 10, 2013
Maximizing the impact of HIV prevention efforts: interventions for couplesAmy Medley, Rachel Baggaley, Pamela Bachanas, et al.
Pageof 6

Showing results (1-10 of 55) with videos related to

Sort By:
Pageof 6
Lancet (London, England)|April 16, 2013
Is Option B+ the best choice?Gottfried Hirnschall, Meg Doherty, Nathan Shaffer
Biomedical Physics & Engineering Express|December 16, 2024
Validation of a rapid algorithm for repeated intensity modulated radiation therapy dose calculationsNathan Shaffer, Jeffrey Snyder, Joel St-Aubin
Journal of Acquired Immune Deficiency Syndromes (1999)|June 5, 2002
Prevention of mother-to-child HIV transmission in the context of a comprehensive AIDS agenda in resource-poor countriesEve M Lackritz, Nathan Shaffer, Chewe Luo
AIDS (London, England)|January 29, 2014
Option B+ for prevention of mother-to-child transmission of HIV in resource-constrained settings: great promise but some early cautionNathan Shaffer, Elaine J Abrams, Renaud Becquet
Medical Physics|January 30, 2026
A tandem reinforcement learning framework for localized prostate cancer treatment planning and machine parameter optimizationNathan Shaffer, Avinash Reddy Mudireddy, Joel St-Aubin
AIDS (London, England)|January 29, 2014
The costs and benefits of Option B+ for the prevention of mother-to-child transmission of HIVChaitra Gopalappa, John Stover, Nathan Shaffer, et al.
Bulletin of the World Health Organization|April 5, 2014
The incremental cost of switching from Option B to Option B+ for the prevention of mother-to-child transmission of HIVLisa O'Brien, Nathan Shaffer, Nalinee Sangrujee, et al.
Lancet (London, England)|December 4, 2009
New WHO HIV treatment and prevention guidelinesSiobhan Crowley, Nigel Rollins, Nathan Shaffer, et al.
Bulletin of the World Health Organization|March 31, 2005
Should nevirapine be used to prevent mother-to-child transmission of HIV among women of unknown serostatus?Tin Tin Sint, François Dabis, Claude Kamenga, et al.
AIDS Care|May 10, 2013
Maximizing the impact of HIV prevention efforts: interventions for couplesAmy Medley, Rachel Baggaley, Pamela Bachanas, et al.
Pageof 6